Albany Cancer Center - Patroon Creek office has reopened. Use lower lot entrance for all appointments.
Albany Medical Center patients should continue to use upper lot entrance to check in for appointments in Suite 210.
Radiation, PET and CT patients use radiation entrance in lower lot. Learn More

Clinical Trials & Research

PH3 Ven+G vs FCR/BR in Fit untreated CLL

A PROSPECTIVE, OPEN-LABEL, MULTICENTER RANDOMIZED PHASE III TRIAL TO COMPARE THE EFFICACY AND SAFETY OF A COMBINED REGIMEN OF OBINUTUZUMAB AND VENETOCLAX VERSUS FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB (FCR)/ BENDAMUSTINE AND RITUXIMAB (BR) IN FIT PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WITHOUT DEL (17P) OR TP53 MUTATION (CO41685)

Disease Types: Leukemia,&nbs

Available at: {clinical_trial_location backspace="7"}PH3 Ven+G vs FCR/BR in Fit untreated CLL, {/clinical_trial_location}

Principal Investigator: {clinical_trial_principle_investi} , {/clinical_trial_principle_investi}

{clinical_trial_description}